KDP microcrystals demonstrate colloidal stability and second-harmonic generation in biocompatible solvents, indicating promise for therapeutic applications.
Potassium dihydrogen phosphate (KDP) microcrystals are biocompatible nonlinear optical materials with promising potential for label-free multiphoton imaging and therapeutic applications. However, because KDP is a highly ionic salt, it is water-soluble but insoluble in many organic solvents, making stabilization in organic solvents a major challenge. We synthesized KDP microcrystals by antisolvent precipitation using a flow-focusing microfluidic device, where aqueous KDP solution and ethanol were rapidly mixed at a high antisolvent-to-solution ratio. XRD and SEM analyses confirmed a tetragonal (42 m) structure and an average particle diameter of 4.42 μm. The microcrystals were dispersed in ethanol (6 mg/mL) and subsequently diluted in water at different water-to-ethanol ratios (19:1, 9:1, 17:3, and 3:1) to form a water-ethanol co-solvent suspension. Stability was evaluated using dynamic light scattering and zeta-potential measurements. Remarkably, the microcrystals formed a stable colloidal suspension for more than 10 days in aqueous ethanol, despite the high solubility of KDP in water. Second-harmonic scattering (SHS) was investigated using a hyper-Rayleigh scattering setup with a Nd:YAG pulsed laser (1064 nm, 50 mJ/pulse, and 10 ns). A strong and well-defined SHS signal at 532 ± 5 nm was detected from the suspensions, confirming their nonlinear optical properties. These results demonstrate, for the first time, that KDP microcrystals can be stabilized in undersaturated aqueous co-solvent while retaining robust second-harmonic generation. Prolonged colloidal stability combined with efficient second-harmonic generation highlights the unique suitability of potassium dihydrogen phosphate for potential next-generation nanobiophotonics applications, including label-free multiphoton microscopy, controlled drug delivery, and nonlinear photoactivation in photodynamic therapy.
No takes yet. Share an insight, caveat, or question.
Paul et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: